ALYA REEVE, M.D., F.A.N.P.A.
Department of
Psychiatry
ASSOCIATE PROFESSOR
Co-Investigator, Continuum of Care Project
Neuropsychiatry Consultant
P.E.R.C.S. (Partnerships for Education, Research, and Community Services)
M.D., University of Connecticut, 1983 Each person we get to know enriches our life. Most of the patients I work
with have more than one chronic health condition. Helping to improve
their functioning and quality of life is intellectually and emotionally
rewarding for me. The cultural, economic and geographic diversity of
our state is unique in the US; it affords me continued delight and
interest as I travel to clinical sites around the state. Neuropsychiatric approaches to mental
disorders encourage the integration of new findings in neuroscience with
recognition of neuronal and habitual patterns and social or societal
influences. The Continuum of Care Project
serves to promote health and medical care for people with intellectual
and developmental disabilities in the state. We are part of a
collaborative effort with other university, state Department of Health,
and insurance providers is working to enhance the training of
professionals to increase access and quality of mental health care
services for people with disabilities around the state. Recent topics that I have mentored medical students or residents
for their research projects include: non-epileptic seizures in survivors
of traumatic brain injury, mental illness diagnoses in people with
autism spectrum disorders, mood changes in people who have received
vague nerve implants for epilepsy.
Residency: University of Connecticut, 1983-1986 & Dartmouth and Institute of Psychiatry, London, UK, 1986-1987
Fellowship: NIMH Research Fellowship in Brain Imaging, 1987-1989 (under Dr. Daniel Weinberger and Dr. Joel Kleinman)
Areas of Specialization: Neuropsychiatry, intellectual and developmental disabilities, traumatic brain injury,
Huntington's disease, epilepsy and non-epileptic seizures, mental health services research
e-mail: areeve@salud.unm.edu or areeve@unm.edu
Extramural Professional Activities:
American Association for Mental Retardation: Technology and Classification Group, member, 1998-2002; NM chapter, president, 1998-2001; Region IV chair elect 2000-2001, chair 2001-2003; Regional representative to the Board 2001-2003; President-elect Medicine Division 2002-2004, president 2004-2006; Member Implementation Committee 2003-present.
American Neuropsychiatric Association: Fellow member; Membership committee, chair, 1992-1995; member, 1995-2000; Program committee, 1995-1998; Research committee, 1997-present.
District Branches of American Psychiatric Association: Psychiatric Medical Association (New Mexico): member, 1990-present; Executive Council member, 1992-1998; President elect, 1993-1994; President 1994-1995; Past-President 1995-1998; Continuing Education Committee Chair 1995-1997
Physicians for Social Responsibility, Inc: New Mexico Chapter: 1989-present, New Hampshire Chapter: 1986-1987, Hartford Chapter: president, 1981-1982, chair, speakers' bureau, 1983-1985
Community Service:
2005-present Board member, New Mexico Guardianship Association
2006-present Board member, NM Brain Injury Association
1998-present Member, planning committee Brain Injury Association annual meeting
Selected Publications:
2006 Reeve A: “Intellectual Disabilities of Developmental Onset”, in Manual of Neuropsychiatric Therapeutics, Coffey, McAllister & Fogel editors, Lippincott Williams and Wilkins, in press.
2006 Reeve A: “Anxiety”, in Medical Care for Children & Adults with Developmental Disabilities, 2nd ed, Rubin and Crocker editors, Paul H. Brooks, p. 483-489
2003 Reeve A: "Clinical Neurophysiology in Neuropsychiatry" , in Neuropsychiatry, 2nd ed, Schiffer, Rao, and Fogel editors, Lippincott, Williams & Wilkins, p.91-127
2002 with ANPA Research Committee: Royall DR et al: “Executive Control Function: A Review of its Promise and Challenges for Clinical Research. A report of the Committee on Research” J Neuropsychiatry and Clin Neurosci 14(4):377-405
2002 with Luckasson, Ruth et al, Mental Retardation: Definition, Classification, and Systems of Supports, Terminology and Classification Committee, AAMR Publishers, -- update and extensive revision of 1992 edition.
2002 Reeve A: "Review of Anxiety Disorders in Older Persons with Developmental Disabilities", NADD publications, R. Pary, editor.
2001 Luckasson R, Reeve A.: “Naming, Defining and Classifying in Mental Retardation.” Mental Retardation, Feb; 39(1): 47-52
2001 Reeve A: "Understanding the Adolescent With Developmental Disabilities" Pediatric Annals, February 30(2): 104-108
2001 Hensley P, Reeve A: “SSRI Induced Akathisia in Head Injury.” Case report. J. Head Trauma Rehabilitation, June; 16(3): 302-5
2000 Reeve A, Witemeyer S, Fedor C, Watkins A: "Report of Three Year Mental Illness and Developmental Disability Clinic in New Mexico", NADD Proceedings, Nov.
1995 Erickson B, Morris DM, Reeve A: “Clozapine-associated postoperative ileus: case report and review of the literature” Arch Gen Psych 52(6): 508-9
1992 Egan M, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ: Treatment of tardive dyskinesia with Vitamin E. American Journal of Psychiatry 149:773‑777
1989 Reeve A, Rose DF, Weinberger DR: Magnetoencephalography: Applications in psychiatry (comment). Archives of General Psychiatry 46(6): 573‑576
1985 Reeve A, Shulman SA, Zimmerman AW, Cassidy SB: Methylphenidate for aggression in a man with ring 22: Report and literature review. Archives of Neurology 42:69‑72
Selected Abstract Presentations:
2006 Reeve A, Weil ER, Hallford GH, Cole C, Warner T: “Reported Neuropsychiatric Symptoms after Traumatic Brain Injury – Issues for Long Term Recovery”. Presented at American Neuropsychiatric Association annual meeting, La Jolla, CA, February.
2004 Schultz J, Reeve A: “Incidence of Traumatic Brain Injury in Patients with Video-EEG Confirmed Non-epileptic Seizures”. Presented at American Neuropsychiatric Association annual meeting, Bal Harbor, FL, February.
1997 Erickson BR, Reeve A, Walter EA, Paine S, Warner T: “Cholesterol Gains Associated with Clozapine Therapy”. Presented at International Congress Schizophrenia Research, Colorado Springs, CO, April.
1997 Kilman A, Reeve A, Cooperman RB, Lesnik PG, Ciesielski KT: “Morphometry of Cerebellar Vermis in Chronic Schizophrenia and Autism: MRI Evidence of Developmental Etiology”. Presented at International Congress Schizophrenia Research, Colorado Springs, CO, April.
Grant and Contract Funding:
Grant in preparation: “Assessing Needs, Developing Treatment, and Enhancing Recovery from Traumatic Brain Injury in Rural New Mexico”
"Outcome Measures of Persons with Traumatic Brain Injury in New Mexico."; Reeve A; 10% effort; HRSA; grant submitted December 2000; awarded August 2001-2004, $70,000/yr.
“Quantified EEG of Ziprasidone and Olanzapine.” Janssen Pharmaceuticals. Unrestricted grant, $5000. Spring 1998.
“Quantified EEG of Ziprasidone and Olanzapine.” Pilot study, Departmental Research Grant. $300. Fall 1997.
“Forty Week, Double-Blind, Study Evaluating the Safety and Efficacy of Two Dose Regimens of Oral CP-88,059-1 (80-120 mg, QD and 40-80 mg, BID) and Haloperidol (5-20 mg daily) in the Maintenance Treatment of Outpatients with Schizophrenia or Schizoaffective Disorder”; Pfizer. $201,000. 1995-1997.
“Open-Label Long-Term Study to Evaluate the Efficacy, Safety and Tolerability of Zotepine 75, 150 and 300 mg Daily Doses in the Treatment of Schizophrenia”; Pfizer. $160,900.00. 1994-2000.
“A Multi-center, Double-blind, Placebo-controlled Parallel Group, Dose-ranging Study to Evaluate the Efficacy, Safety and Tolerability of Zotepine 75, 150 and 300 mg Daily Doses in the Treatment of Acute Schizophrenia”; Pfizer. $198,940.00. 1994-1995.
“Physiologic Study of Generalized Anxiety Disorder”; Upjohn Co. $67,173.00. 1993-1995.
"Magnetoencephalography of Auditory Evoked Responses in Patients with Schizophrenia," National Alliance for Research on Schizophrenia and Depression, Young Investigator Award, $45,448, 2 years, July 1990 - June 1993.
"Quantitative Electroencephalography of Patients with Schizophrenia During Cognitive Tasks," Research Allocation Committee, University of New Mexico, $14,594, fall 1989.
Updated